Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology.

Steyn JD, Wiesner L, du Plessis LH, Grobler AF, Smith PJ, Chan WC, Haynes RK, Kotzé AF.

Int J Pharm. 2011 Jul 29;414(1-2):260-6. doi: 10.1016/j.ijpharm.2011.05.003. Epub 2011 May 7.

PMID:
21596127
2.

Artemisone effective against murine cerebral malaria.

Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillan JA, Chan HW, Chan WC, Barenholz Y, Haynes RK, Golenser J.

Malar J. 2010 Aug 9;9:227. doi: 10.1186/1475-2875-9-227.

3.

Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model.

Dunay IR, Chan WC, Haynes RK, Sibley LD.

Antimicrob Agents Chemother. 2009 Oct;53(10):4450-6. doi: 10.1128/AAC.00502-09. Epub 2009 Jul 27.

4.

Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.

Isacchi B, Bergonzi MC, Grazioso M, Righeschi C, Pietretti A, Severini C, Bilia AR.

Eur J Pharm Biopharm. 2012 Apr;80(3):528-34. doi: 10.1016/j.ejpb.2011.11.015. Epub 2011 Nov 28.

PMID:
22142592
5.

Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.

Mandawgade SD, Sharma S, Pathak S, Patravale VB.

Int J Pharm. 2008 Oct 1;362(1-2):179-83. doi: 10.1016/j.ijpharm.2008.06.021. Epub 2008 Jul 3.

PMID:
18652886
6.

Assessment of the induction of dormant ring stages in Plasmodium falciparum parasites by artemisone and artemisone entrapped in Pheroid vesicles in vitro.

Grobler L, Chavchich M, Haynes RK, Edstein MD, Grobler AF.

Antimicrob Agents Chemother. 2014 Dec;58(12):7579-82. doi: 10.1128/AAC.02707-14. Epub 2014 Oct 6.

7.

Malaria and artemisinin derivatives: an updated review.

Ansari MT, Saify ZS, Sultana N, Ahmad I, Saeed-Ul-Hassan S, Tariq I, Khanum M.

Mini Rev Med Chem. 2013 Nov;13(13):1879-902. Review.

PMID:
24070206
8.

First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.

Nagelschmitz J, Voith B, Wensing G, Roemer A, Fugmann B, Haynes RK, Kotecka BM, Rieckmann KH, Edstein MD.

Antimicrob Agents Chemother. 2008 Sep;52(9):3085-91. doi: 10.1128/AAC.01585-07. Epub 2008 Jun 16.

9.

Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.

Vivas L, Rattray L, Stewart LB, Robinson BL, Fugmann B, Haynes RK, Peters W, Croft SL.

J Antimicrob Chemother. 2007 Apr;59(4):658-65. Epub 2007 Mar 2.

PMID:
17337512
10.

[Combined antimalarial therapy using artemisinin].

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.

PMID:
15305693
11.

Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice.

Isacchi B, Arrigucci S, la Marca G, Bergonzi MC, Vannucchi MG, Novelli A, Bilia AR.

J Liposome Res. 2011 Sep;21(3):237-44. doi: 10.3109/08982104.2010.539185. Epub 2010 Dec 16.

PMID:
21158702
12.

Design of Drug Delivery Systems Containing Artemisinin and Its Derivatives.

Aderibigbe BA.

Molecules. 2017 Feb 20;22(2). pii: E323. doi: 10.3390/molecules22020323. Review.

13.

Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.

Joshi M, Pathak S, Sharma S, Patravale V.

Int J Pharm. 2008 Oct 1;362(1-2):172-8. doi: 10.1016/j.ijpharm.2008.06.012. Epub 2008 Jun 19.

PMID:
18611435
14.

Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.

Aditya NP, Patankar S, Madhusudhan B, Murthy RS, Souto EB.

Eur J Pharm Sci. 2010 Aug 11;40(5):448-55. doi: 10.1016/j.ejps.2010.05.007. Epub 2010 May 20.

PMID:
20493255
15.

Pharmacokinetic and toxicological profile of artemisinin compounds: an update.

Medhi B, Patyar S, Rao RS, Byrav D S P, Prakash A.

Pharmacology. 2009;84(6):323-32. doi: 10.1159/000252658. Epub 2009 Oct 23. Review.

16.

Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.

Svensson US, Alin H, Karlsson MO, Bergqvist Y, Ashton M.

Eur J Clin Pharmacol. 2002 Aug;58(5):339-51. Epub 2002 Jul 13.

PMID:
12185558
17.

Controlled release of artemisone for the treatment of experimental cerebral malaria.

Golenser J, Buchholz V, Bagheri A, Nasereddin A, Dzikowski R, Guo J, Hunt NH, Eyal S, Vakruk N, Greiner A.

Parasit Vectors. 2017 Mar 1;10(1):117. doi: 10.1186/s13071-017-2018-7.

18.

Artemisinin-based combination therapies and their introduction in Japan.

Kano S.

J Infect Chemother. 2010 Dec;16(6):375-82. doi: 10.1007/s10156-010-0077-1. Epub 2010 Jun 10. Review.

PMID:
20535521
19.

Antimalarial activity of dihydroartemisinin derivatives by transdermal application.

Lin AJ, Ager AL Jr, Klayman DL.

Am J Trop Med Hyg. 1994 Jun;50(6):777-83.

PMID:
8024074
20.

Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.

Ansari MT, Batty KT, Iqbal I, Sunderland VB.

Arch Pharm Res. 2011 May;34(5):757-65. doi: 10.1007/s12272-011-0509-1. Epub 2011 Jun 9.

PMID:
21656361

Supplemental Content

Support Center